PWM
PRME icon

Palumbo Wealth Management’s Prime Medicine PRME Stock Holding History

Palumbo Wealth Management’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$383K Buy
103,801
+1,555
+2% +$5.16K 0.08% 169
2026
Q1 		$356K Buy
102,246
+16,707
+20% +$63.6K 0.09% 155
2025
Q4 		$297K Sell
85,539
-6,996
-8% -$31.1K 0.07% 173
2025
Q3 		$513K Sell
92,535
-90,823
-50% -$369K 0.16% 89
2025
Q2 		$453K Buy
183,358
+87,896
+92% +$135K 0.14% 113
2025
Q1 		$190K Buy
+95,462
New +$244K 0.06% 167

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Palumbo Wealth Management's PRME Position: Q2 2026 in Review

Palumbo Wealth Management increased its Prime Medicine (PRME) stake by 1.5% in Q2 2026, buying an estimated $5.16K and bringing the position to 103,801 shares worth $383K. The position accounts for 0.08% of the portfolio, ranked #169.

Palumbo Wealth Management first reported a position in PRME in Q1 2025 and has held it in 6 quarters since. The position peaked at $513K in Q3 2025. 187 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • Palumbo Wealth Management held 103,801 shares of Prime Medicine worth $383K as of Q2 2026.
  • Palumbo Wealth Management bought 1,555 Prime Medicine shares in Q2 2026, an estimated $5.16K.
  • Prime Medicine made up 0.08% of Palumbo Wealth Management's portfolio in Q2 2026, its #169 holding.
  • Palumbo Wealth Management first reported a position in Prime Medicine in Q1 2025 and has held it in 6 quarters since.
  • Palumbo Wealth Management's Prime Medicine position peaked at $513K in Q3 2025.
  • 187 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on Palumbo Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.